Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department

Study Overview
=================
Brief Summary
-----------------
This study evaluates the efficacy of melatonin 5mg in the prevention of Delirium in the older adults in emergency department. Half of the participants will receive melatonin 5mg and the other half will use a starch-based placebo.

Detailed Description
-----------------
Melatonia is useful for the treatment of sleep disorders due to the interruption of the circadian rhythm, secondary to alterations caused by the environment. The doses of 5 to 10mg oral or sublingual can improve the quality of the sleep-wake cycle and alertness in short-term use. Mechanism of action of melatonin are: Binding to membrane receptors: MT1 and MT2 coupled to G protein - Union to nuclear receptors. - Interaction with cytosolic proteins. - Antioxidant of direct and indirect action. - Interaction with mitochondria. Melatonin circulates 80% bound to albumin and the rest in free form in plasma, 85-90% is metabolized by 6-hydroxymelatonin in the liver, which is then conjugated with sulfuric acid (70-80%) or glucuronic ( 5-3%), and is excreted in urine and feces. Melatonin and its metabolites act as catalytic antioxidants to safeguard mitochondrial electron transfer reactions, therefore, increases the efficiency of energy metabolism. Melatonin synthesis decreases significantly as age progresses and changes in the circadian cycle have been associated with accelerated aging.

Official Title
-----------------
Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department

Conditions
-----------------
Delirium in Old Age

Intervention / Treatment
-----------------
* Drug: Melatonin 5 mg


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Men and women over 60 who enter the emergency department with a stay in the ward for more than 8 hours and who will remain hospitalized for more than 48 hours due to admission pathology. Patients who agree to participate in the study by signing an informed consent (Signature by patient and / or family member). Exclusion Criteria: Patients with a history of dementia or previous neurological diseases. Patients with a history of psychiatric disorder. Patients diagnosed with any type of liver disease. Warfarin treatment. Delirium data on admission to the emergency department. Patients under invasive mechanical ventilation and sedation.

Ages Eligible for Study
-----------------
Minimum Age: 60 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Parallel Assignament
Masking: Triple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Melatonin 5mg<br>Melatonin 5mg, every 24 hours for 14 days | Drug: Melatonin 5 mg<br>* Placebo<br>* Other names: Cronocaps;|
| Placebo Comparator: Placebo<br>Starch based placebo, every 24 hours for 14 days | Drug: Melatonin 5 mg<br>* Placebo<br>* Other names: Cronocaps;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Delirium | Diagnosis based Confusional Assessment Method Scale | 14 days |